Skip to main content

RHUMBLINE ADVISERS

Position in AUTL — Autolus Therapeutics plc

CIK 1115418 BOSTON, MA

Position in AUTL

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$62,022
+$13,790 QoQ
Shares Held
38,764
+10.9% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#44
of 84 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AUTL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $1,404,724,682 across 329 Biotechnology names. AUTL ranks #288 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in AUTL

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $62,022 38,764
2026-03-31 $48,232 34,951
2025-12-31 $64,179 32,251
2025-09-30 $26,701 16,381
2025-06-30 $38,096 16,709
2025-03-31 $11,428 7,373
2024-12-31 $14,899 6,340
2024-09-30 $22,168 6,107
2024-06-30 $20,190 5,802
2024-03-31 $14,763 2,314
2023-12-31 $7,393 1,148
2023-09-30 $2,674 1,148
2023-06-30 $2,922 1,228